Clinical Rheumatology

, Volume 24, Issue 3, pp 239–243 | Cite as

Serological screening for celiac disease in premenopausal women with idiopathic osteoporosis

  • Onur Armagan
  • Tercan Uz
  • Funda Tascioglu
  • Omer Colak
  • Cengiz Oner
  • Yurdanur Akgun
Original Article


The aim of this study was to perform serological testing to screen for celiac disease (CD) among premenopausal women with idiopathic osteoporosis and to investigate the bone turnover in patients who are seropositive for CD. We studied 89 premenopausal women with idiopathic osteoporosis. The serological screening protocol was based on a two-level evaluation. The first level consisted of determining serum level of IgA antigliadin antibodies (AGA). Subjects who were negative for IgA AGA were classified as not having CD, while samples testing positive for IgA AGA underwent a second level of the screening process. For the second level of screening, the serum IgA endomysial antibody (EMA) test was performed. Bone metabolism was evaluated by serum calcium (Ca), phosphorus, alkaline phosphatase, parathyroid hormone (PTH), 25 (OH) vitamin D, osteocalcin (OC), urinary deoxypyridinoline (dPD), and 24-h urinary calcium levels. Of the 89 patients evaluated, 17 were found to have positive IgA AGA tests (19%) and 9 were found to be positive for EMA (10.11%). EMA-positive patients showed lower values of serum Ca (p<0.05) and 25 (OH) vitamin D (p<0.01) and significantly higher values of PTH (p<0.01) compared with the EMA-negative patients. The level of urinary dPD was found to be significantly higher in EMA-positive patients (p<0.05). The results of this study suggest that all patients with idiopathic osteoporosis should be screened for CD by measurement of EMA. Additionally, we believe that serological screening for CD and detection of such patients will allow determination of the most convenient treatment strategies for osteoporosis.


Antiendomysial antibodies Celiac disease Idiopathic osteoporosis 


  1. 1.
    Kanis JA, Melton LJ, Christiansen C et al (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137–1141PubMedGoogle Scholar
  2. 2.
    Raisz LG, Kream BE, Lorenzo JA (1998) Metabolic bone diseases. In: Wilson JD, Foster DW, Kronenbergh HM, Larsen PR (eds) Williams textbook of endocrinology, 9th edn. W.B. Saunders, Philadelphia, pp 1211–1239Google Scholar
  3. 3.
    Marsh M (1992) Gluten, major histocompatibility complex and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (“celiac sprue”). Gastroenterology 102:330–354PubMedGoogle Scholar
  4. 4.
    Corazza GR, Di Sario A, Cecchetti L et al (1995) Bone mass and metabolism in patients with celiac disease. Gastroenterology 109:122–128PubMedGoogle Scholar
  5. 5.
    Kemppainen T, Kroger H, Janatuinen E, et al (1999) Osteoporosis in adult patients with celiac disease. Bone 24:249–255CrossRefPubMedGoogle Scholar
  6. 6.
    Hadjivassiliou M, Grunewald RA, Chattopadhyay AK et al (1998) Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet 352:1582–1585CrossRefPubMedGoogle Scholar
  7. 7.
    Collin P, Vilska S, Heinonen PK et al (1996) Infertility and celiac disease. Gut 39:382–384PubMedGoogle Scholar
  8. 8.
    Catassi C, Ratsch IM, Fabiani E et al (1994) Coeliac disease in the year 2000: exploring the iceberg. Lancet 343:200–203CrossRefPubMedGoogle Scholar
  9. 9.
    Ferguson A, Arranz E, O’Mahony S (1993) Clinical and pathological spectrum of celiac disease-active, silent, latent, potential. Gut 34:150–151PubMedGoogle Scholar
  10. 10.
    Corazza GR, Frisoni M, Treggiari EA et al (1993) Subclinical coeliac sprue. Increasing occurrence and clues to its diagnosis. J Clin Gastroenterol 16:16–21PubMedGoogle Scholar
  11. 11.
    Giacci C, Cirillo M, Sollazzo R et al (1995) Gender and clinical presentation of adult celiac disease. Scand J Gastroenterol 30:1077–1081PubMedGoogle Scholar
  12. 12.
    Vazquez H, Mazure R, Gonzales D et al (2000) Risk of fractures in celiac disease patients: a cross-sectional, case-control study. Am J Gastroenterol 95:183–189PubMedGoogle Scholar
  13. 13.
    Mazure R, Vazquez H, Gonzales D et al (1994) Bone mineral affection in asymptomatic adult patients with celiac disease. Am J Gastroenterol 89:2130–2134PubMedGoogle Scholar
  14. 14.
    Cellier C, Flobert C, Cormier C et al (2000) Severe osteopenia in symptom-free adults with a childhood diagnosis of coeliac disease. Lancet 355:806CrossRefPubMedGoogle Scholar
  15. 15.
    Mustalahti K, Collin P, Sievanen H et al (1999) Osteopenia in patients with clinically silent celiac disease warrant screening. Lancet 28:744–745CrossRefGoogle Scholar
  16. 16.
    Lindh E, Ljunghall S, Larson K et al (1992) Screening for antibodies against gliadin in patients with osteoporosis. J Int Med 231:1403–1406Google Scholar
  17. 17.
    Maki M (1995) The humoral immune system in celiac disease. Baillieres Clin Gastroenterol 9:231–249CrossRefPubMedGoogle Scholar
  18. 18.
    Kelly TL (1990) Bone mineral density reference databases for American men and women. J Bone Miner Res 5:5249Google Scholar
  19. 19.
    Vogelsang H, Genser D, Wyatt J et al (1995) Screening for celiac disease: a prospective study on the value of non-invasive tests. Am J Gastroenterol 90:394–398PubMedGoogle Scholar
  20. 20.
    Carroccio A, Iacono G, Montalto G (1993) Immunologic and absorptive tests in celiac disease: can they replace intestinal biopsies? Scand J Gastroenterol 28:673–676PubMedGoogle Scholar
  21. 21.
    Rostami K, Kerchaert J, Tiemessen R et al (1999) Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol 94:888–894CrossRefPubMedGoogle Scholar
  22. 22.
    Ferreira M, Davies SL, Butler M et al (1992) Endomysial antibody: is it the best screening test for celiac disease? Gut 33:1633–1637PubMedGoogle Scholar
  23. 23.
    Grodzinsky E, Hed J, Skogh T (1994) IgA antiendomysium antibodies have a high positive predictive value for celiac disease in asymptomatic patients. Allergy 38:2034–2037Google Scholar
  24. 24.
    Hallert C, Astrom J (1982) Psychic disturbances in adult celiac disease. II. Physiological findings. Scand J Gastroenterol 17:21–24PubMedGoogle Scholar
  25. 25.
    Nuti R, Martini G Valenti R et al (2001) Prevalence of undiagnosed celiac syndrome in osteoporotic women. J Int Med 250:361–366CrossRefGoogle Scholar
  26. 26.
    Gonzales D, Sugai E, Gomez JC et al (2002) Is it necessary to screen for celiac disease in postmenopausal osteoporotic women? Calcif Tissue Int 71:141–144CrossRefPubMedGoogle Scholar
  27. 27.
    Keaveny AP, Freaney R, McKenna MJ et al (1996) Bone remodeling indices and secondary hyperparathyroidism in celiac disease. Am J Gastroenterol 91:1226–1231PubMedGoogle Scholar
  28. 28.
    Gannage MH, Abikaram G, Nasr F et al (1998) Osteomalacia secondary to celiac disease, primary hyperparathyroidism and Graves’ disease. Am J Med Sci 315:136–139CrossRefPubMedGoogle Scholar
  29. 29.
    Selby PY, Davies M, Adams JE et al (1999) Bone loss is related to secondary hyperparathyroidism. J Bone Miner Res 14:652–657PubMedGoogle Scholar
  30. 30.
    Forneri MC, Pedreira S, Nibeloni S et al (1998) Pre- and post-treatment serum levels of cytokines IL-I beta, IL-6, and IL-I receptor antagonist in celiac disease. Are they related to the associated osteopenia? Am J Gastroenterol 93:413–418PubMedGoogle Scholar
  31. 31.
    Farrell RJ, Kelly CP (2001) Diagnosis of celiac sprue. Am J Gastroenterol 96:3227–3246CrossRefGoogle Scholar
  32. 32.
    Fasano A (1996) Where have all the American celiacs gone? Acta Paediatr 85:20–24Google Scholar
  33. 33.
    Johnston SD, Watson RGP, McMillian SA et al (1997) Prevalence of celiac disease in Northern Ireland. Lancet 350:1370Google Scholar
  34. 34.
    Logan R (1996) Screening for celiac disease-has the time come for mass screening? Acta Paediatr 412:49–51Google Scholar
  35. 35.
    Feighery C, Weir DG, Whelan A et al (1998) Diagnosis of gluten sensitive enteropathy: is exclusive reliance on histology appropriate? Eur J Gastroenterol Hepatol 10:919–935PubMedGoogle Scholar
  36. 36.
    Rossi TM, Kumar V, Lerner A et al (1988) Relationship of endomysial antibodies to jejunal mucosal pathology: specificity towards both symptomatic and asymptomatic celiacs. J Pediatr Gastroenterol Nutr 7:858–863PubMedGoogle Scholar
  37. 37.
    Trier JS (1991) Celiac sprue. N Engl J Med 325:1709–1719PubMedGoogle Scholar

Copyright information

© Clinical Rheumatology 2004

Authors and Affiliations

  • Onur Armagan
    • 1
  • Tercan Uz
    • 2
  • Funda Tascioglu
    • 1
  • Omer Colak
    • 3
  • Cengiz Oner
    • 1
  • Yurdanur Akgun
    • 2
  1. 1.Department of Physical Therapy and Rehabilitation, Faculty of MedicineOsmangazi UniversityEskisehirTurkey
  2. 2.Department of Clinical Microbiology, Faculty of MedicineOsmangazi UniversityEskisehirTurkey
  3. 3.Department of Biochemistry, Faculty of MedicineOsmangazi UniversityEskisehirTurkey

Personalised recommendations